cCARE
cCARE is California's largest full-service private oncology and hematology practice, operating 8 locations across the San Diego and Fresno areas with 30+ physicians, delivering comprehensive cancer care — medical and radiation oncology, imaging, clinical trials, and survivorship programs — to adult cancer patients.
- Company typePrivate
- Founded1992
- HeadquartersFresno, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What cCARE does
cCARE (legal name: California Cancer Associates for Research & Excellence) is the largest full-service private oncology and hematology practice in California, operating eight clinical locations across the San Diego and Fresno metropolitan areas with approximately 30 physicians and 251–500 total employees. The platform delivers the full continuum of adult cancer care under one roof across multiple sites, spanning medical oncology (chemotherapy, immunotherapy, targeted therapy), radiation oncology, surgical oncology, neurosurgery, hematology, stem cell transplantation, hormone therapy, advanced imaging (CT, MRI, PET), cancer screening, genetic counseling, physician dispensing, and supportive services including palliative care, integrative medicine, and survivorship programs. A clinical trials program offers patients access to investigational therapies, and the practice operates research and quality functions supported by ACHC accreditation.
The business operates a professional services revenue model, billing per treatment course or cycle through major commercial insurance, Medicare Advantage, and self-pay (financed via MedFinancial WeCare payment plans), with bill payment handled through a Personapay online portal. Distribution is hybrid: direct patient appointment requests via ccare.com, physician referrals through a dedicated referring physician portal and online form, and institutional partnerships (notably Saint Agnes Medical Center in Fresno). The company is affiliated with Integrated Oncology Network (ION), a strategic operating partner of 60+ centers nationwide, and is governed as a physician-led organization with Dr. Jedidiah Monson serving as Board President and Medical Director of Radiation/Imaging.
Growth and capability expansion have been driven by capacity build-out (a 65,000-square-foot Fresno flagship, more than double the prior 31,000-square-foot facility), multi-specialty tuck-in acquisitions (California Urology and Central Valley Medical & Women's Imaging in August 2025), and sustained physician recruiting across gynecologic oncology, hematology/medical oncology, and Southern California geographies. The practice originated as a three-physician medical oncology group in Fresno in 1992 and has since evolved into a vertically integrated community oncology platform serving California communities across multiple sites.
cCARE firmographics
Firmographics- Name
- cCARE
- Legal name
- California Cancer Associates for Research & Excellence
- Website
- https://ccare.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- cCARE is California's largest full-service private oncology and hematology practice, operating 8 locations across the San Diego and Fresno areas with 30+ physicians, delivering comprehensive cancer care — medical and radiation oncology, imaging, clinical trials, and survivorship programs — to adult cancer patients.
- Ownership category
- akta.pro rank
Where cCARE is headquartered
LocationHeadquarters
- HQ city
- Fresno
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
cCARE business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Medical Oncology Services: Revenue generated from chemotherapy, targeted therapy, immunotherapy, and hematology treatments billed per treatment cycle through insurance and Medicare.
- Radiation Oncology Services: Radiation therapy treatments billed per course, including external beam radiation and specialized radiation procedures.
- Imaging and Diagnostic Services: Revenue from diagnostic imaging including CT, MRI, PET scans, and cancer screening services.
- Physician Dispensing: Oral cancer medication dispensing services providing medications directly to patients.
- Clinical Trials: Research program providing access to investigational treatments.
- Survivorship and Support Services: Palliative care, integrative medicine, survivorship care, and support groups.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance-based care – most major insurance plans and Medicare Advantage accepted. |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
cCARE product offering
Product offeringCore offering
cCARE (California Cancer Associates for Research & Excellence) is the largest full-service private oncology and hematology practice in California, providing comprehensive cancer care across 8 clinical locations in the San Diego and Fresno areas. The practice delivers medical oncology, chemotherapy, immunotherapy, targeted therapy, radiation oncology, surgical oncology, hematology, imaging, genetic counseling, clinical trials, and survivorship and palliative care services, accepting most insurance plans including Medicare Advantage.
Product overview
cCARE (California Cancer Associates for Research & Excellence) is the largest full-service private oncology and hematology practice in California, operating eight clinical and business offices in the San Diego and Fresno areas. The company offers an integrated, comprehensive cancer care platform centered on Medical Oncology (chemotherapy, targeted therapy, immunotherapy) and Radiation Oncology, supplemented by surgical oncology, hematology, neurosurgery, stem cell transplantation, and hormone therapy. The portfolio includes cancer screening and diagnosis services (mammography, imaging, clinical labs), a robust clinical trials program for cutting-edge research, survivorship care for post-treatment support, palliative care, and complementary/integrative medicine. Patient-facing digital services include a patient portal for online access to records and scheduling, while the physician dispensing service provides oral medications directly. The company delivers care through a network of 28+ physicians and healthcare professionals across eight California locations.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology Comprehensive cancer treatment services delivered by board-certified medical oncologists, including chemotherapy, targeted therapy, and immunotherapy administration for adult cancer patients.
- Radiation Oncology Advanced radiation therapy treatment using high-energy rays to kill cancer cells, administered by radiation oncologists with access to state-of-the-art equipment.
- Cancer Surgery Surgical removal of cancerous tissue performed by surgical oncologists, including breast surgery and other cancer-specific procedures.
- Hematology Specialized treatment for blood-related cancers and conditions including leukemia, lymphoma, and myeloma, provided by hematology specialists.
- Immunotherapy Cancer treatment that uses the patient's immune system to fight cancer cells through medication and biological therapies.
- Targeted Therapy Precision cancer treatment using drugs that target specific genes, proteins, or the tissue environment that contributes to cancer growth.
- Hormone Therapy Treatment that adds, blocks, or removes hormones to slow or stop the growth of certain cancers.
- Stem Cell Transplantation Procedure to replace damaged or destroyed bone marrow with healthy stem cells, used for certain blood cancers.
- Neurosurgery Surgical treatment for brain and spinal cord tumors performed by specialized neurosurgeons.
- Cancer Screening & Diagnosis Early detection services including mammography, colonoscopy, lung cancer screening, and imaging services to diagnose cancer at early stages.
- Imaging Services Advanced imaging technology including CT scans, MRI, PET scans, and X-rays for cancer diagnosis and staging.
- Clinical Trials Access to cutting-edge cancer research through participation in clinical trials offering experimental treatments to qualifying patients.
- Survivorship Care Extended care program focused on the specific needs of cancer survivors, including follow-up care, lifestyle guidance, and support groups.
- Palliative Care Specialized medical care for patients with serious illness, focusing on relief from symptoms, pain, and stress.
- Complementary & Integrative Medicine Holistic health services including supportive therapies alongside conventional cancer treatment.
- Physician Dispensing Services On-site pharmacy service allowing physicians to dispense oral cancer medications directly to patients.
Quantifiable outcome
- cCARE has been recognized with the 2009 HOPE (Hematology and Oncology Practice Excellence) award as the best example of a medium-sized practice in Clinical Best Practices nationwide.
- +2 more outcomes
Companies that use cCARE
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
cCARE technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
cCARE partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and major.
- Integrated Oncology Network (ION)corecCARE is affiliated with Integrated Oncology Network (ION), which partners directly with physicians, hospitals, and healthcare providers to offer the latest cancer services and technologies. Founded in 2008, ION has grown to over 60 centers across the country, providing diagnostic testing, radiation oncology, medical oncology, urology, and ancillary services. cCARE Board President Dr. Jedidiah Monson and CEO of ION Barry Tanner jointly announce physician additions and strategic initiatives.
- California UrologymajorCalifornia Urology joined the cCARE family in August 2025 as part of cCARE's expansion of care access in the Central Valley. Six physicians from California Urology joined cCARE, expanding the network's urology and oncology services in the Fresno area.
- Central Valley Medical & Women's Imaging (CVMI)majorCentral Valley Medical & Women's Imaging (CVMI) joined the cCARE family in August 2025, welcoming three advanced practice providers. This partnership expands diagnostic imaging and women's imaging services in the Central Valley alongside cCARE's Fresno oncology operations.
- Saint Agnes Medical CentermajorcCARE partnered with Saint Agnes Medical Center in Fresno to develop a new 65,000-square-foot outpatient cancer center, expanding from the original 31,000-square-foot facility. The partnership aimed to create a less clinical, more comforting care environment with natural lighting and distinct decor. The center includes laboratory, infusion areas, radiation oncology suites, two PET scanners, and physician dispensing services.
Scale indicators5 records
Recent moves8 records
Expansion highlights5 records
cCARE competitors and assessment
Company assessmentDirect peers
- The US Oncology Network (McKesson): Largest U.S. community oncology network affiliated with McKesson, providing medical oncology, radiation, infusion, and clinical trials to independent practices nationwide — directly comparable to cCARE's community oncology platform model.
- OneOncology: PE-backed platform (TPG) partnering with leading community oncology practices across multiple states to deliver medical oncology, infusion, imaging, and clinical trials — same multi-site private practice model as cCARE.
- GenesisCare: Global private oncology and cardiology provider offering radiation oncology, medical oncology, and integrated cancer care across Australia, Europe, and the U.S. — operates a comparable multi-site private oncology model.
- Texas Oncology: One of the largest community-based oncology practices in the U.S., offering medical oncology, radiation, surgery, imaging, and clinical trials across more than 200 Texas sites — directly mirrors cCARE's full-service private practice approach at greater scale.
Broad incumbents
- City of Hope: Leading NCI-designated comprehensive cancer center in Southern California with extensive medical, radiation, and surgical oncology programs plus research and clinical trials — major academic competitor to cCARE in the LA/San Diego corridor.
- Stanford Cancer Institute: Northern California academic cancer center providing oncology care, clinical trials, and translational research — competitive with cCARE's Fresno-area oncology catchment for tertiary cases.
- UCLA Health (Jonsson Comprehensive Cancer Center): Academic medical center in Los Angeles offering comprehensive oncology and hematology services, clinical trials, and cancer screening — broader portfolio but competes for complex oncology referrals in Southern California.
- Dignity Health / CommonSpirit (Cancer Care): Large nonprofit Catholic health system operating oncology programs across California, including hospital-integrated infusion, radiation, and surgery — competes with cCARE in the Fresno and Central Valley markets.
- Sarah Cannon (HCA Healthcare): HCA's cancer institute operating across a broad hospital network, providing medical oncology, radiation, and clinical trials through hospital-integrated programs — overlaps with cCARE but embedded in a much larger health system.
Regional players
- Kaiser Permanente Oncology: Vertically integrated California health plan and provider operating its own oncology programs across Northern and Southern California — large incumbent referral source/competitor in the geographies where cCARE operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
cCARE social profiles
Digital presencecCARE financial estimates
Financial estimateRevenue estimate
Valuation estimate
cCARE leadership team
Management profileNumber of profiles
Profiles3 records
cCARE subsidiaries and ownership
Company hierarchySubsidiaries2 records
cCARE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
cCARE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about cCARE
What does cCARE do?
cCARE (California Cancer Associates for Research & Excellence) is the largest full-service private oncology and hematology practice in California, providing comprehensive cancer care across 8 clinical locations in the San Diego and Fresno areas. The practice delivers medical oncology, chemotherapy, immunotherapy, targeted therapy, radiation oncology, surgical oncology, hematology, imaging, genetic counseling, clinical trials, and survivorship and palliative care services, accepting most insurance plans including Medicare Advantage.
Is cCARE a public or private company?
cCARE is a private company. It is classified as corporate owned and is currently operating.
When was cCARE founded?
cCARE was founded in 1992. It employs 251 to 500 people.
Where is cCARE based?
cCARE is headquartered in Fresno, United States, in the North America region.
How does cCARE make money?
Six revenue lines are on record. Medical Oncology Services are the primary driver. The others are radiation Oncology Services, imaging and Diagnostic Services, physician Dispensing, clinical Trials and survivorship and Support Services.
Who are cCARE's main competitors?
Direct peers on record are The US Oncology Network (McKesson), OneOncology, GenesisCare and Texas Oncology. Broad incumbents are City of Hope, Stanford Cancer Institute, UCLA Health (Jonsson Comprehensive Cancer Center), Dignity Health / CommonSpirit (Cancer Care) and Sarah Cannon (HCA Healthcare). Kaiser Permanente Oncology is listed as a regional player.
Does cCARE have an API?
No public API is recorded for cCARE.